AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Mrna infographic8/12/2023 ![]() ![]() Our standard is 660 pixels, but you can customize how the statistic is displayed to suit your site by setting the width and the display size. Simply copy the HTML code that is shown for the relevant statistic in order to integrate it. Yes, Statista allows the easy integration of many infographics on other websites. This decision drew skepticism from human rights groups due to its focus on profit instead of sharing of knowledge and technology with local facilities.Ĭan I integrate infographics into my blog or website? In February of 2022, BioNTech announced the planned deployment of mobile vaccine factory containers to Africa to increase vaccination rates. For example, BioNTech generated 19 billion Euros in revenue with its vaccine alone in 2021, while Moderna made $18 billion in the same year. While vaccine makers like BioNTech and Moderna cite lacking capacities and qualifications in African, Latin American and Asian countries for their stance against the suspension of coronavirus vaccine patents, the enormous profit margins are likely another factor in the equation. The African continent houses eight such facilities in countries like Egypt and Tunisia, while Brazil is the country with the most qualifying factories in Latin America. The majority of these facilities are located in India (55) and China (34), many of which have already produced the corresponding country's own vaccines like Covaxin, Covilo or CoronaVac, which in turn have not yet been approved for use in the West. With the corresponding knowledge transferred, every company on the list put together by MSF fulfills the requirement for "good manufacturing praxis" (GMP) or has already exported a sterile pharmaceutical product to either the European Union or the United States. As our chart based on data collected by Médecins sans Frontières (MSF) shows, 120 non-Western pharmaceutical facilities would have theoretically been ready to mass-produce highly effective mRNA vaccines at the end of 2021.Īs MSF points out, mRNA vaccines are simpler to produce and "more predictable and easier to transfer to other manufacturers" than vaccines relying on older technology. Both measures were largely opposed by the European Commission and pharmaceutical companies like Moderna and BioNTech. This stark contrast is the result of a variety of reasons, but experts agree that there are two key ways to speed up vaccine production and deployment in economically poorer African, Latin American and Asian countries: Technology transfer and the suspension of vaccine patents at least for the duration of the pandemic. The gap between low and upper middle income countries, in particular, seems unbridgable, with vaccination rates of 16 percent in the former and 79 percent in the latter. The cost is also lower than other platforms and will continue to decrease as the technology expands.According to calculations by Our World in Data, 61 percent of the world population has received two doses of one of the several coronavirus vaccines available on the market. The manufacturing is sequence-independent, which makes it highly adaptable to different pathogens. Production: mRNA can be quickly designed and scaled up, if necessary. ![]() These advances increase the amount of spike protein produced on your cells, thereby stimulating a more effective immune response. Recent technology has modified the mRNA molecule to make it more stable and packaged the molecules in fats (called lipids), increasing cell delivery efficiency. mRNA is made through a cell-independent process and does not require inactivation thus, it poses no safety concerns due to contamination with toxic agents.Įfficacy: mRNA is rapidly degraded in the body, and cells don't readily take up foreign mRNA. Other strategies such as protein-based or inactivated vaccines also require chemicals and cell cultures to produce. Safety: Unlike live-attenuated or viral-vectored vaccines, mRNA is non-infectious and poses no concern for DNA integration-mainly because it cannot enter the nucleus which contains DNA. What are the advantages over other vaccine strategies? If you are infected with SARS-CoV-2, your immune system recognizes the same spike protein and can quickly induce an immune response to fight the virus. Your immune system sees the protein and learns how to make an immune response against it. After injection, the cells in your arm muscles pick up the mRNA, make the protein, and display it on the cell's surface. SARS-CoV-2 vaccines include instructions to make one portion of the virus (the spike protein) that is harmless by itself. Messenger RNA (mRNA) provides a recipe that your cells can use to make proteins. What is mRNA, and how do mRNA vaccines work? ![]()
0 Comments
Read More
Leave a Reply. |